Back to Search
Start Over
Selenium supplementation of lung epithelial cells enhances nuclear factor E2-related factor 2 (Nrf2) activation following thioredoxin reductase inhibition.
- Source :
-
Redox biology [Redox Biol] 2018 Oct; Vol. 19, pp. 331-338. Date of Electronic Publication: 2018 Sep 05. - Publication Year :
- 2018
-
Abstract
- The trace element selenium (Se) contributes to redox signaling, antioxidant defense, and immune responses in critically ill neonatal and adult patients. Se is required for the synthesis and function of selenoenzymes including thioredoxin (Trx) reductase-1 (TXNRD1) and glutathione peroxidases (GPx). We have previously identified TXNRD1, primarily expressed by airway epithelia, as a promising therapeutic target to prevent lung injury, likely via nuclear factor E2-related factor 2 (Nrf2)-dependent mechanisms. The present studies utilized the TXNRD1 inhibitor auranofin (AFN) to test the hypothesis that Se positively influences Nrf2 activation and selenoenzyme responses in lung epithelial cells. Murine transformed Club cells (mtCCs) were supplemented with 0, 10, 25, or 100 nM Na <subscript>2</subscript> SeO <subscript>3</subscript> to create a range of Se conditions and were cultured in the presence or absence of 0.5 μM AFN. TXNRD1 and GPX2 protein expression and enzymatic activity were significantly greater upon Se supplementation (p < 0.05). AFN treatment (0.5 μM AFN for 1 h) significantly inhibited TXNRD1 but not GPx activity (p < 0.001). Recovery of TXNRD1 activity following AFN treatment was significantly enhanced by Se supplementation (p < 0.041). Finally, AFN-induced Nrf2 transcriptional activation was significantly greater in mtCCs supplemented in 25 or 100 nM Na <subscript>2</subscript> SeO <subscript>3</subscript> when compared to non-supplemented controls (p < 0.05). Our novel studies indicate that Se levels positively influence Nrf2 activation and selenoenzyme responses following TXNRD1 inhibition. These data suggest that Se status significantly influences physiologic responses to TXNRD1 inhibitors. In conclusion, correction of clinical Se deficiency, if present, will be necessary for optimal therapeutic effectiveness of TXNRD1 inhibitors in the prevention of lung disease.<br /> (Copyright © 2018 The Authors. Published by Elsevier B.V. All rights reserved.)
- Subjects :
- Animals
Cell Line
Epithelial Cells drug effects
Epithelial Cells metabolism
Glutathione Peroxidase metabolism
Lung cytology
Lung metabolism
Mice
Respiratory Mucosa cytology
Respiratory Mucosa metabolism
Thioredoxin Reductase 1 metabolism
Lung drug effects
NF-E2-Related Factor 2 metabolism
Respiratory Mucosa drug effects
Selenium pharmacology
Thioredoxin Reductase 1 antagonists & inhibitors
Subjects
Details
- Language :
- English
- ISSN :
- 2213-2317
- Volume :
- 19
- Database :
- MEDLINE
- Journal :
- Redox biology
- Publication Type :
- Academic Journal
- Accession number :
- 30212802
- Full Text :
- https://doi.org/10.1016/j.redox.2018.07.020